M. Chi

Involvement of Tissue Transglutaminase in Endothelin 1–Induced Hypertrophy in Cultured Neonatal Rat Cardiomyocytes

Xiao-yun Ma, L. Liang, Jian-quan Zheng, 2009, Hypertension.

Inhibition of Endothelin-1 and Hypoxia-induced Pulmonary Pressor Responses in the Rat by a Novel Selective Endothelin-A Receptor Antagonist, Di-n-butylaminocarbamyl-l-leucyl-d-tryptophanyl-d-4-chloro-Phe

Ke-liang Liu, Zheng Yong, Ling-lei Kong, 2010, Journal of cardiovascular pharmacology.

Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.

Ke-liang Liu, Jian-quan Zheng, M. Chi, 2008, Pulmonary pharmacology & therapeutics.

Screening of RNA molecules inhibiting human acetylcholinesterase by virtue of systematic evolution of ligands by exponential enrichment.

M. Chi, Xing-mei Zhang, Ning-Sheng Shao, 2003, Acta pharmacologica Sinica.

The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: Serotonin, norepinephrine and dopamine reuptake inhibitor

Dan Zhou, M. Chi, Nana Gao, 2012, Pharmacology Biochemistry and Behavior.

Production of human liver prolidase by Saccharomyces cerevisiae as host cells.

Shu-hao Wang, Manluan Sun, Min Liu, 2004, Acta pharmacologica Sinica.

[Direct effect of VX and soman on nicotinic receptors].

S. M. Chen, M. Chi, 1986, Zhongguo yao li xue bao = Acta pharmacologica Sinica.